TLSA•benzinga•
Reported Earlier, Tiziana Life Sciences Secures $5M in Direct Offering Of 5.3M Shares At $0.95/ Share for Immunotherapy Development
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on October 31, 2024 by benzinga